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This study investigated the relationship between the type of material and the 
concentration of IgA in human milk stored at two temperatures over tim .  Twelve breastfeeding 
mothers participated in the study with samples of milk obtained at loc ions of the participant’s 
preference and transported to the laboratory in a sterile Snappies PP container stored in a cooler 
filled with ice.  The sample was divided up and pipetted into 12 containers.  IgA concentrations 
were determined by enzyme-linked immunosorbent assay at time zero, 9, 24, 48, 72 and 168 
hours.  Milk IgA concentration decreased in all containers, with the exc ption of polycarbonate 
from 72 hours to 168 hours in -20°C. In 4°C, the results of IgA concentrations sh wed volatility 
and did not indicate a stable trend.  The data suggested that the concentration of milk IgA was 
more affected by temperature and the type of material may not have a significant impact on IgA. 
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In present-day America, women are returning to their jobs earlier after giving birth than previous 
generations who took longer maternity leaves. Those who choose to breastfeed, find it nearly 
impossible to feed their infants during their work hours so they must pump then store milk in 
containers in refrigerators and freezers.  Stored milk is then used to feed infants whe  the women 
are at work or away from their infants.  As a result, it is increasingly difficult for mothers to 
follow the American Academy of Pediatrics (AAP)’s recently amended recommendation that 
mothers breastfeed their infants for at least one year.  At least 50 percent of women who are 
employed when they become pregnant return to work by the time their children are three months 
old, making this study important to analyze the effects of storage time and temperature 
conditions normally found in refrigerators and freezers (Tyler, 2000). Fortunately, refrigerators 
and freezers are available to give mothers the option of storing their milk for future eedings to 
ensure their infants receive milk when breastfeeding is inconvenient or not possible.  Ideally,
stored milk should be identical to freshly expressed milk in terms of concentration and viability 
of different biocomponents.   It is even more critical for infants in a Neonatal Intensive Care Unit 
(NICU) to have their mothers pump the optimal milk so they receive the highest quantity of 
immunologic factors. One in eight babies are born prematurely and placed in the NICU due to 
the rising number of twins and triplets from assisted reproduction, induced prematu  deliveries, 
and Cesarean sections (Maugh, 2008).  It is publicized that the colostrum of mothers of preterm
infants has higher concentrations of IgA, up to 12 g/L to 0.5-1.0 g/L in mature milk (Butte et al., 
1984) or 310.5 mg/g in preterm colostrum compared to 168.2 mg/g in term colostrum (Groer & 
Walker, 1996; Gross et al., 1981a).  
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Previous studies in the last 30 years show that human milk loses important components 
due to a variety of factors, including temperature and adherence of components to the materials 
of the storage containers.  In a groundbreaking study by Goldblum et al. (1981), the 
concentration of secretory IgA in milk is shown to have no change in glass and polypro y ene.  
However, in a report by Williamson and Murti (1996), there is a loss of IgA in glass with the 
mean count of IgA in human milk stored in glass decreasing after seven hours.  SIgA is stable in 
rigid polyethylene containers, but is reduced by 60 percent after being stored in flexible 
polyethylene bags (Goldblum et al., 1981).  
IgA has been selected as the milk component for analysis because several lactation 
consultants and experts recommended IgA due to its important role in the immune system of the 
nursing infant (Lactnet postings, 11-27-08 to 12-4-08).  An additional feature is that IgA is found 
to be stable at 4°C and -20°C (Evans, Ryley, Neale, Dodge, & Lewarne, 1978, Pardou, Serruys, 
Mascart-Lemone, Dramaix, & Vis, 1994).  Lawrence and Lawrence (2005) recommends up to 48 
hours of milk storage in the refrigerator and up to six months in a standard home freezer.  
Purpose of the Thesis 
This project will study different storage container materials to find the minimum impact 
on the adherence of IgA in human milk by quantifying the loss of IgA due to adherence.  The 
goal is to show whether current recommendations proposed by lactation consultants and doctors 
regarding container types, temperature, and time are still appropriate for optimal levels of IgA. 
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IgA and sIgA 
IgA antibodies are the first line of defense against a wide berth of pathogens in the human 
body.  They bind to bacteria and toxins, preventing them from invading epithelial cells; 
particularly in the mucus epithelium of the intestinal and respiratory tracts.   By preventing these 
microbes, no inflammation is induced as other antibodies and phagocytes are not ctivated (Hale 
& Hartmann, 2007). IgA also neutralize toxins or bacteria by absorption.  There are two forms of 
IgA found in the human body; the first is monomeric IgA with a molecular weight of 160 kDa 
and the second is the 390 kDa dimeric type.  The dimeric form is two monomeric IgA linked by 
a J-chain by disulfide bonds (Janeway, Travers, White & Shlomachik, 2001).  
 
Figure 1.  sIgA with J Chain and Secretory Component 
 (http://www.phasmatodea.org/ap2/immunology2_notes.html) 
IgA in the blood system is mainly monomeric, whereas in the mucosal linings, IgA is 
usually in the dimeric form, (Janeway et al., 2001).  The dimeric fo m is referred to as ecretory 
IgA (sIgA) and is the principal isotype in infants as sIgA can be transported across the epithelium 
from the mother’s mammary glands to the milk.  It is the predominant antibody in human milk, 
making up 80 to 90% of the antibodies in the colostrum and mature milk (Hae & Hartmann, 
2007).  In the lactating mammary gland, plasma cells synthesize IgA under the basement 
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membrane with two IgA antibodies binding them to a J chain. A complex of the J-chain and IgA 
antibodies attaches to a poly-Ig receptor and diffuses across the basement membrane.  After 
being transported through the basement membrane, sIgA enters the mammary gland, which 
produces human milk and is later lactated to the feeding infant (Janeway et al., 2001).   
 
Figure 2.  Transport of sIgA through the secretory epithelium via three methods 
(http://www.med.uio.no/rh/patologi/liipat/secretory_immunity/pictures/TI-
fig1big.htm)  
The role of sIgA is vital to the infant as it plays different functions in the intestinal 
development of neonates, including promoting intestinal adaptation to extrauterine life and 
establishment of beneficial microbiota.  It also prevents infection and inflammation as well as 
compensates for the developmental immaturity of the intestine (Donovan, 2006).  In infants, 
sIgA is effective against enterotoxin-producing E. coli, Campylobacter, Shigella, salmonellae, 
streptococci, staphylococci, and pneumococci (Glass et al., 1983; Ruiz-Palacios et al., 1990; 
Hayani et al., 1992; Cruz et al., 1983; Waterspiel et al., 1994).  SIgA is also shown to be active 
against a large range of viruses, such as polio virus types 1, 2, 3, coxsackie virus types, ECHO 
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virus types 6, 9, as well as rotaviruses (Welsh & May, 1979).  The infant does not attain adult 
levels of IgA until two months old.   
IgA and sIgA is shown to be unaffected by freezing for four weeks (Tully, Jones & Tully, 
2001).  Cycles of freezing/thawing do not affect the composition of IgA (Evans, Ryley, Neale, 
Dodge, & Lewarne, 1978, Pardou, Serruys, Mascart-Lemone, Dramaix, & Vis, 1994).   
However, it is possible that sIgA proteins may undergo protein denaturalization during thawing 
after being frozen (Kerner, Quan, Yang et al., 1987). The average conc ntration of IgA in human 
milk quantified by the ELISA technique during the first year of lactation is approximately 0.388 
to 1.105 grams per liter (g/L) (Weaver, Arthur, Bunn, & Thomas, 1997).  The results from 
O’Connor, Schmidt, Carroll-Pankhurst, and Olness (1998) show a range of 0.32 to 0.49 g/l of 
sIgA in human milk using the radial immunodiffusion technique.   
Packaging Materials 
The following human milk storage containers are chosen for their material composition:  
1. Medela Freezing and Storage rigid polypropylene 80 mL bottles- 090607-A part 61095 100 
2. Snappies sterile rigid polypropylene 70 mL containers- Lot 071107 Part 10253 Mold #252 
3. Ameda rigid polycarbonate milk bottles – Lot 7J058 
4. Medela Pump and Save flexible polyethylene (HDPE) storage bags- Lot 39209A 73321 
5. Ball canning glass- 14400-80400, 05-604 




There are four different materials being examined in the thesis: polypropylene, 
polycarbonate, high density polyethylene, and glass.  There are two types of plastics. The first 
type of plastics is flexible yielding materials, such as film, foil, or paper sheeting, which acquire 
a pliable shape when filled and sealed. The Medela flexible polyethy ene bag falls under this 
category.  The second group is rigid packaging, which maintains its hape and dimensions 
throughout its lifecycle after thermoformed.  All rigid plastic containers belong to this category. 
Polypropylene (PP), identified by Resin Identification Code #5, is used in food packaging 
applications, including take-out containers, lids and domes, cups, tubs for yogurt and margarine, 
ketchup bottles, and medicine bottles.  They are also utilized for housewares, media packaging, 
bottles for cosmetics and household industrial chemicals, plastic syringes, and air/water filtration 
systems.  The advantages of PP are that bottles can be hot-filled and may have a built-in handle.  
The material has excellent optical clarity in biaxially-oriented films and can be injection molded, 
thermoformed, and stretch blow molded.  They have low moisture vapor transmission, and are 
inert to acids, alkalis, and most solvents.  The density of polypropylene used for bottles, labels, 
and clear films is low, approximately 0.89 to 0.93 grams/ cm3.  Polypropylene’s low specific 
gravity and good stiffness can result in fewer pounds of resin used per thousand packaging units, 
saving costs to the manufacturer.  There are no known safety concerns or worries about 
consumer applications.  
Polycarbonate (PC) is identified by Resin Identification Code #7 and is used in meical 
devices.  It is also used for containers, such as reusable/microwaveable housewares and reusable 
bottles, which include water cooler bottles, sports bottles, and baby bottles.  PC is commonly 
blended with other plastics.  Additionally, PC is a durable plastic that can withstand rel tively 
  
7 
high temperatures; hence, it is an ideal choice for applications requiring frequent reuse and 
washing, sterilizing or microwave heating (PlasticsEurope, 2008).  The advantages 
polycarbonate provides are toughness, dimensional stability, optical clarity, high heat resistance, 
and excellent electrical resistance.  PC is also recyclable, and is a high-value resin for recycling 
due to its relatively high cost per pound of resin (PlasticsEurope, 2008). The cost factors 
discourage the use of polycarbonate in packaging and other single-use applications.  PC is 
portrayed negatively in the public eye due to a monomer, known as bisphenol A or BPA, from 
which PC is manufactured.   However, the Food and Drug Administration, the EU Scientific 
Committee on Food, and the Japanese Ministry of the Environment have determined the amount 
of residual BPA in PC to be typically less than 50 parts-per-million, declaring PC safe for use 
(FDA, 2008).  
High density polyethylene (HDPE) is identified by Resin Identification Code #2; it is 
known for its low cost in manufacturing.  It also has an excellent moisture barrier and does not 
typically break when dropped.  The disadvantages of HDPE are its permeability to oxygen and a 
high cold-flow rate (Soroka, 2002).  
Glass is usually created from combining silica sand mixed with carbonates, such as 
limestone, soda ash, or alumina in high heat.  Advantages of using glass include its inertness to 
most chemicals. In addition, glass does leach out materials, altering he taste of food.  Glass has 
excellent impermeability to oxygen for long-term storage of prducts sensitive to oxygen.  It is 
also stable at high temperatures and maintains a rigid shape.  The disadvantages of using glass 
are its brittleness, which makes glass prone to breaking at specific heights.  It is also more 
expensive to manufacture than plastic resins (Soroka, 2002). 
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Company’s Criteria for Selecting a Material for Their Storage Containers  
Companies manufacturing bottles used in the thesis were contacted by -mail.  This  
e-mail included questions on why the company chose the specific material for their containers.  
Only two companies, Medela and Snappies, responded. 
Snappies 
Nancy Fleming, the Commercial Product Manager for the Snappies container at Thermo 
Fisher Scientific, responded to my e-mail inquiry about the selection of PP in Snappies 
containers.  The company chose polypropylene because most of the company’s other products 
are made from polypropylene. As a result, Thermo Fisher Scientific had a strong relationship 
with its resin supplier.  They also had previous packaging experience when working in the dairy 
industry prior the company entering the human milk market.  Their results showed that milk fat 
did not stick to polypropylene, leading to more consistent results in testing.  From the 
manufacturing perspective, the suppliers and mold engineers chose polypro y ene because 
human milk needed to be stored in a food-grade plastic container.  Th y also wanted a resin that 
could flow through the injection-molding equipment and had a low-residual odor. 
Medela 
Simdon Craig, the Product Introduction Engineer at Medela, responded to my e-mail 
about their selection of materials in their two containers.  Craig mentions their bottles were not 
regulated medical devices; hence, they did not consider them to be measurement devices.  For 
the Medela flexible polyethylene bags, Craig indicated that the company uses a HDPE inner liner 
due to its food contact properties and water vapor barrier properties.  They chose this resin for 
their rigid PP containers over other resins, indicating previous studie  showing PP as a good 
material for storing human breast milk.  Medela chose polypropylene for its translucent clarity 
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and its ability to withstand cleaning and sterilization requirements FDA requires.  Medela also 
made a decision ten years ago to not use PC in their containers s the company was aware of the 
leaching of bisphenol A into liquids. 
Hypothesis 
Rigid PP containers will be the optimal storage containers for the least IgA retention at 
4˚C and -20˚C.  Rigid PP containers will be followed by other materials in order from best to 




Method / Acquirement of Samples 
1. The RIT Human Subjects Research Office has approved the participation of human subjects. 
2.  Lactation consultants, clubs, and organizations targeting new moms, along with word-of-
mouth have been used to contact possible candidates.    
3.  Eligibility for the project has been determined based on voluntary participation and 
willingness to donate milk 4 to 30 weeks post-delivery. Ideally, the number of participan s 
was 20 to 25 to achieve statistical significance. 
4. Participants were briefed on the study goals, risks, and privacy issues before voluntarily 
agreeing to sign an Informed Consent form prior to participation. 
5.  Information on the age of mothers and that of their infants were taken to explain possible 
outliers that may appear in the data analysis. 
6. The researcher went to locations of the participant’s preference to collect human milk. 
7.  Sterile Snappies polypropylene containers were used to collect each participant’s milk.  
8. A single expression of milk from one or both breasts, by breast pump or hand expression, 
were collected in a sterile Snappies polypropylene tube. 
9. Breast milk samples were labeled at the site with a reference number to protect the identity of 
the participant. The sample was transported to RIT, chilled in a cooler filled with ice.   
10. The reference numbers and names were kept in a safe in Professor Deanna Jacobs’ office,  
70-1313 in the Golisano College of Computing and Information Sciences. 
11. The reference number used for each participant was not published in the thesis.  Letter  (A, 
B, and C) were used in the published data to protect the identity of the participants. 
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12. After arriving in the lab, time zero was established when the sample in the Snappies 
polypropylene bottle was shaken and three 800-microliter aliquots of the sample were plac d 
in separate 1.5 mL centrifuge tubes. The average of the three was the benchmark for IgA 
levels at time zero.   
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Transferring Breast Milk from Snappies Transport Container  
to the Appropriate Containers 
1. 60 mL of milk received from participants were pipetted from the Snappies transport 
container to the different containers involved in the experiment. Each container had 5 mL of 
sample. 
2. There were 12 containers altogether.  One of each type of container was stored in the 
refrigerator and one in the freezer, which resulted in six containers in the refrigerator and six  
in the freezer. 
3. The containers were placed next to each other in the same area in the freezer/fridge to reduce 
variability due to location of samples. 
4. For the refrigerated samples, three different aliquots were taken from each container and 
combined to make one sample at 9, 24, 48, and 72 hours.  Frozen samples were analyzed at 
72 and 168 hours.  Each container was warmed under warm running water 45 seconds for 
refrigerated samples and 130 seconds for frozen samples.   
5. Warming of the refrigerated and frozen samples followed the standard procedure provid d by 
lactation consultants on thawing milk and were applied to all containers in this experiment in 
the previous step. 
6. 800 microliters of milk for each container were measured and centrifuged in the tabletop 
centrifuge (MicroSpin 12, Sorvall Instruments) for 20 minutes.  400 microliters of the bottom 
whey layer were pipetted and placed into a centrifuge tube.  The top layer, compromised of 
cream, was discarded.   Appropriate dilution of 1:2 or 1:4 of each sample combined with 
sample diluent was performed. 
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Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol 
1. For the ELISA procedure, the Bethyl Laboratories E80-102 manual was referenced. 
2. A change was made at the end of Step B1 in the Bethyl manual.  Instead of following 
Bethyl’s recommendation of washing the wells by aspirating each well, th  “flick and tap” 
method was used.  
3. The samples were diluted by a factor of 2 or 4 in Step B2. This was done as previous 
literature showed the average concentration of IgA to be approximately 700 ng/mL, As a 
result, 1:2 dilutions were performed to ensure the samples fit the standard curve of 7.8 ng/ml 
to 1000 ng/ml.  
4. The substrate’s reaction with 3, 3’, 5, 5’-tetramethylbenzidine (TMB) wells were read by an 
at ELISA ELx800 UV reader (Bio-Tek Instruments) at 450 nm.   
5. KC Junior (Bio-Tek) was used to convert absorbance readings into IgA concentrations by 
comparing the samples to the standards provided by Bethyl.  
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Table 1. A Sample Set Up of a 96-Well ELISA Plate 














































































































































































































































Legend:  The table shows the set up of blanks, standards, and samples in a 96- well plate.  There are two replicates 




1. For each subject, the numbers of replicates at time zero were averaged together.  The average 
became the baseline for all replicates at each time point compared. 
2. The standard deviation from the baseline was determined for elimination of outliers. 
3. Individual replicates for each container were compared to the baseline. If a r plicate showed 
a concentration higher than the standard deviation range, then it was omitted from the results. 
4. The remaining replicates were divided by the baseline and converted to a percentage. 
5. The percentages were added to represent an average percentage for each cntainer at each 
time point. 
6. The subjects were added together to create the final percent of IgA remaining in milk in each 
container at every time point.  
7. Each container was plotted onto a line graph with the X-axis values representing percent of 




Twelve subjects participated in the study, with four subjects excluded from the results 
due to contamination of the samples during the data-gathering process.  Contamination occurred 
during time zero and nine hours, with the samples assumed to be compromised when the blanks 
had larger readings than the background readings.  In a few cases, the blanks were shown to have 
absorbance values as high as the samples. If the blanks displayed high absorbance values, then 
the standard curves created from the known standards provided by Bethyl, Inc could not be 
established. This led to the omission of the samples at that specific time point from the study. 
The subjects used in the study were labeled as B through L.  The rang  of time from lactation of 
the milk to the laboratory was anywhere from 15 minutes to one hour and 15 minutes. Most 
samples had a transportation average time of 30 to 35 minutes. There wer  six time points (0, 9, 
24, 48, 72, and 168 hours) and two temperatures (4 °C and -20 °C) in the data.  As seen in Table 
2, the mean standard deviation of samples taken at time zero was 338.5 with a high value of 
697.6 and a low value of 122.4.   
Table 2.  Age of Mother and Infant with Mean IgA Concentration at Time Zro 
Subject Age of Subject Age of Infant Mean IgA Concentration 
(ng/ml) 
Standard Deviation 
B 29 years 4 weeks 1892.3 697.6 
C 30 years 5 weeks 3116.9 122.4 
F   1889.3 312.7 
H 30 years 28 weeks 3081.5 525.3 
I 27 years 9 weeks 1062.5 263.1 
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Subject Age of Subject Age of Infant Mean IgA Concentration 
(ng/ml) 
Standard Deviation 
J 33 years 44 weeks 3198.0 355.0 
K 32 years 4 weeks 1051.0 196.1 
L 30 years 28 weeks 1231.1 235.7 
 
Nine-hour values are not included in the results for subjects B, I, and K, In addition, 
subject F’s 48 and 72-hour marks are omitted from the results. Subjects H, J, and L do not have 
their 24-hour values in their results.  Subject H does not include values from 48 hours.  The 
omitted values are ignored because the wells at these time points showed inconsistent results due 
to contamination of the samples from human error or the researcher’s technique. 
Table 3 shows how many samples were used to represent the amount of IgA remaining in 
the human milk over time.  The nine-hour mark has an unbalanced number of samples because 
the Snappies and Axifeed containers have one extra sample.  The 24-hour mark has only three 
samples and the 48-hour mark has five samples.  The 72-hour samples and the 168-hour samples 
have seven subjects. The higher number of subjects in the 72-hour and 168-hour samples 
compared to the earlier time points is due to reliable standard curves and the low absorbance 
values from the blanks.  
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Table 3.  The Number of Samples in Each Container used in the Data. 






Bag Axifeed HDPE Ball Glass 
9 hours 4 5 4 4 5 4 
24 hours 3 3 3 3 3 3 
48 hours 5 5 5 5 5 5 
72 hours 7 7 7 7 7 7 








HDPE Ball Glass 
72 hours 7 7 7 7 7 7 
168 hours 7 7 7 7 7 7 
Legend:  Each value represents the number of subjects used to represent the data. 
Tables 5 and 6 include the average percentage of IgA concentration remaining in each 
container compared to the baseline of IgA quantified at time zero. The last two rows of the tables 
show the average of all time points for each container as well as the standard devition.  
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9 76.16 71.92 72.33 72.26 71.47 69.38 
24 76.53 85.43 83.15 71.59 79.85 78.24 
48 73.39 74.52 71.88 78.32 76.99 73.38 
72 82.71 74.34 76.61 76.16 78.53 81.68 
Average 77.20 76.55 75.99 74.58 76.71 75.67 
Standard 
Deviation 23.54 22.12 20.67 15.98 22.88 18.69 
 
















72 83.29 83.37 85.25 90.20 89.06 86.30 
168 84.40 82.72 82.85 84.55 85.94 82.09 
Average 83.84 83.04 84.05 87.37 87.50 84.19 
Standard 
Deviation 20.48 18.94 16.90 15.66 15.47 21.01 
 
Figures 3 and 4 are a visual representation of Tables 4 and 5, which s ow the 
concentrations of IgA varying from temperature to temperature as well as container to container.  
In the -20°C freezer at 72 hours (Figure 3), all containers performed very close to each other, 
ranging from 83.3% of   IgA in the Ameda PC container to 90.2% of IgA left in human milk in 
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the Medela PE bag.  The concentration of IgA reduces in all containers from 72 hours to 168 
hours, with the exception of Ameda, which remains stable.  The range varies from 85.9% in 
Axifeed to 82.1% in glass.  None of the containers went below 80% at -20°C in both time points.   
Figure 4 shows how each material performs in the least retention of IgA in the 4°C 
samples.  The IgA concentration starts out low at nine hours and steadily increases to 24 hours in 
all containers, with the exception of Medela PE bags and Ameda PC containers.  IgA 
concentration drops down at 48 hours for all containers, with the exception of Medela PE bags, 
which increases from 71.6 to78.3%.  There are mixed results in IgA concentration in different 
materials at 72 hours.  For all 4°C samples, there is consistency in the performance of all 
containers throughout the duration of the experiment as the range of IgA concentration goes from 
69% to 85% as compared to the original concentration. The worst performing container is the 
Ball glass with 69.4% of IgA in the human milk at nine hours compared to time zero.  The best 
performing material is the Medela PE bag with 85.4% of IgA in the human milk at 24 hours.   
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Figure 3. Percentage of IgA Remaining in Human Milk Stored in the Freezer (-20°C). 
Legend:  Percentage of IgA in the samples taken from b ttles since time zero.  Two time points are used to analyze 
the -20°C (freezer) samples. 
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Figure 4. Percentage of IgA Remaining in Human Milk Stored in the Refrigerator (4°C).  
Legend:  Percentage of IgA in the samples taken from b ttles since time zero.  Four time points are used to analyze 
the 4°C (refrigerator) samples. 
Further statistical analysis was performed on the 72 hour mark to compare the influence 
of the material on IgA stored at 4°C and -20°C.  It was the only timepoint when both the 
refrigerator and freezer samples were present.  Eight subjects were used to compare both 
temperatures.  These subjects were B, C, F, H, I, J, K, and L.   
Table 6 shows the results of the concentration of IgA at 72 hours.  
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Table 6.  Concentration of IgA (ng/ml) in Each Container Stored at 4°C and -20°C for 72 
Hours. 
  Mean 
Standard 
Deviation Minimum Median Maximum 
Ameda PC -20°C 1887 1071 841 1323 3942 
 4°C 1792 883 846 1429 4892 
Snappies PP -20°C 1751 942 841 1337 4054 
 4°C 1533 501 736 1679 2449 
Medela Rigid 
PP -20°C 1761 887 773 1477 3205 
 4°C 1710 871 609 1393 3882 
Medela 
Flexible PE  -20°C 1944 1065 737 1394 4156 
 4°C 1522 488 699 1456 2365 
Axifeed HDPE -20°C 2170 1421 829 1697 5615 
 4°C 1542 517 845 1451 2648 
Glass -20°C 1971 1303 345 1360 5862 
 4°C 1586 494 716 1571 2321 
Legend:  Three observations were made for each container.  Design was unbalanced as Subject K in the Snappies PP 
and Subject I in the Medela Flexible PE at 4°C had only two observations, so the third observation came from the 
mean of the first two observations.  
 
The first significant analysis demonstrated that each container had a higher mean in the    
-20°C as compared to 4°C; however, the median was lower in -20°C for all containers. The 
Axifeed HDPE and the Medela PP containers had higher means and median in the freezer.  The 
standard deviation was higher in the freezer for all containers.  
The next significant observation was the interaction of three variables: temperature, 
subject, and container (see Table 7).  When the subjects were random with the container and 
temperature values being fixed, the temperature (p=0.277) and subject (p =0.050) were more 
significant on influencing the concentration of IgA than the container (p=0.521).  There was a 
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strong interaction between the subjects and temperatures (p=0.00) when compared against the 
interaction of containers and temperatures (p=0.168).   
Table 7. Interaction of Different Subjects, Containers, and Temperatures at 72 Hours. 
Source P-value Source P-value 
SubjectA_72 0.050 SubjectA_72 0.050 
Container_72 0.521 Container_72 0.514 
Temp_72 0.277 Temp_72 0.277 
SubjectA_72*Temp_72 0.000 SubjectA_72*Temp_72 0.000 





The transportation method was derived from the study by Goldblum et al. (1981).  The 
method varied a little as their study mentioned the collection of milk usually took ten minutes 
with transportation in 4°C in an ice chest to the laboratory.  The partici nt contributed two 
times for the study; one sample was stored in a Pyrex glass cylinder while the other sample was 
stored in a polyethylene container.  In this study, only one contribution was taken from each 
participant with the average transportation time taking 30 minutes.  The sample was stored in a 
polypropylene container rather than a Pyrex glass cylinder and a polyethylene container.  The 
study by Friend, Shahani, Long, and Vaughn (1983) was also referenced as the researchers 
collected milk at participants’ houses and traveled to the laboratory.  The decision of starting 
time zero in this study was based on the Friend et al study, where thei  experiment started at the 
point they arrived at their laboratory.  
Different subjects had different concentrations of IgA ranging from 1051.0 to 3198.0 
ng/ml (Table 2).  Previous literature noted different variables may affect th  concentration of IgA 
in different women, including environmental stresses, the health of mother and infant, and the 
week of gestational age of the infant (Weaver et al., 1998, & Goldman et al., 1982, & Prentice, 
Prentice, & Cole, 1984, & Hennart, Brasseur, Delgone-Desnoeck et al., 1991).  The standard 
deviation of the subjects at time zero (338.5 ng/ml) was shown t be less than the published 
standard deviation of 1360 ng/ml (1.360 g/l) in the paper of Koenig, Diniz, Barbosa, and Vaz 
(2005).  The smaller standard deviation was encouraging; indicating that the data obtained in this 
experiment may have been more consistent than previous studies.  
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The technique used in the experiment may have led to the inconsistency of the results 
from the samples.  It is strongly believed the inconsistency of samples in the shorter time points 
was due to lack of concentration or drowsiness when working in the lab nine to twelve hours in 
the first 24 hours of experiment for each subject.  The 48, 72, and 168 hours may have come out 
better due to more time apart between experiments.  
The sample size in the study is very small, creating a higher volatility in the data as 
compared to larger sample sizes.  For instance, only three out ofeight subjects were used in the 
4°C samples at the 24-hour mark, while the nine-hour and 48-hour marks included fo r or five 
subjects. This could explain why most of the containers increased at l ast 5% from the nine-hour 
mark to 24-hour mark while the percentage decreased at least 5% at the 48 hour mark.  Even 
with a small sample size and a large range of high and low values in each container, the average 
of all percentages for each container showed each container perform d very consistently 
throughout the duration of the experiment.  When all the containers were compared to each 
other, they essentially performed very closely, with a range of 74.6 to 77.2% in the 4°C samples 
and 83.0 to 87.5% in the -20°C samples. 
It is exciting to show a material did not retain more than 20% of the original 
concentration in the -20°C samples. Further, it was encouraging to know that loss of 
concentration was not necessarily directly related to the retention of the IgA by the material, but 
rather attributed to the protein denaturalization that may occur during the thawing process as 
noted in the study by Kerner et al. (1987).  When the 20°C samples wer compared to the 4°C 
samples, there was less loss of IgA in the human milk, supporting Lawrence and Lawrence 
(2005)’s recommendation that frozen samples may be left for six months.  
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Further research, however, must be taken to study to determine whether the length of 
duration is still appropriate for maintaining IgA levels.  This could mean the lower temperature 
may be more optimal in terms of IgA remaining inside the milk. A lower temperature may be 
credited with less movement of IgA; thus, reducing the material and IgA interaction. 
Alternatively, a lower temperature may prevent the degradation of IgA as microbes reproduce at 
a faster rate in 4°C as compared to -20°C.   
A surprising finding indicated the concentration of IgA found in PE bags in the freezer 
and refrigerator is drastically higher than reported in earlier studies, which showed PE losing up 
to 60% of sIgA antibodies specific for E.coli during storage (Arnold, 1995).  This may be 
attributed to Medela adding a HDPE inner lining to the PE bag.  It is also possible that the 
performance of the PE bag has improved over 20 years with the addition of HDPE linings.  
The 72-hour statistical analysis comparing the refrigerator and freezer samples indicated 
the null hypothesis demonstrated a strong correlation of temperature and subject interaction, with 
little, if any, influence from the containers.  Figures 2 and 3 aswell as the statistical analysis 
showed less IgA loss in the freezer.  The p-values showed no specific type of material made a 
significant difference on the retention of IgA, disproving the hypothesis that loss of IgA was 




The Rigid PP containers were not the optimal storage containers in both temperatures, 
which disproved the hypothesis.  HDPE (Axifeed) performed the best while Rigid PP (Snappies 
and Medela) fared the worst in -20°C.  At 4°C, there was no clear evidence to confirm the best 
performing material.    
The decrease of IgA from 72 hours to 169 hours may be attributed to IgA de radation as 
the 168 hour samples went through two thawing cycles as compared to one thawing cycle for the 
72 hour samples. As a result, the impact of the IgA concentration may be from the extra 
freezing/thawing cycles; not from time. 
The current recommendations of the lactation consultants and doctors are still practical 
after seeing these results. An important issue is to prove is whether temperature is a greater 
influence on IgA levels. Women do not need to worry about the container they use to achieve the 
best results in terms of protecting one biocomponent of human milk studied in this thesis.  
Further, mothers do not need to concern themselves with the selection of the optimal container in 
terms of preserving IgA levels. Rather, mothers are encouraged to focus more important factors, 
including the ease of the container for the infant and mother; the shelf space available in the 
refrigerator and freezer; and the compatibility of the container with the breast pump.  Results 
indicate that three days is the maximum length of time for storing breast milk in refrigerators.  If 





The small number of samples used in the experiment is the limiting factor, discouraging 
the significance of the results.  More samples are needed to prove whether the results from the 
experiment maintain the same trend for a larger population.  However, r sults presented from 
this research is a good indication that storage container material may not be the primary factor 
causing decreased levels of IgA, but rather degradation may be attri uted to temperature.  With 
the data seen in this experiment, the next step is to study a larger collection of human milk to 
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Appendix A - Consent Form 
Matthew Jenkins 
Packaging Science Dept. 
Email: mdj7463@rit.edu 
 
Thank you for agreeing to participate in this study which will take place from 3/10/08 to 6/20/08.  
This form outlines the purposes of the study and provides a description of your involvement and 
rights as a participant. 
 
The purposes of this project are: 
 
1.) To gain insight into the topic of the influence of different milk containers on the retention of 
an immune protein called Immunoglobulin A in breast milk stored several days in the 
refrigerator and freezer after pumping.  
 
The methods used to collect information are explained below: 
 
A. 20 mothers who are feeding their infants with breast milk 4 to 30 weeks after delivery 
will voluntarily give breast milk once or twice during the study. 
 
B. A single pump from both breasts, either by breast pump or hand, will be placed in a 
sterile container provided by the researcher. 
 
C. That is all that is required from you, the milk will be taken to a biology laboratory  RIT 
where it will be analyzed for the amount of IgA. 
 
You are encouraged to ask any questions anytime about the nature and goals of this study and the 
methods that I am using.  Your suggestions and concerns are very important to me so please 
contact me at any time at the email address listed at the top of the paper. 
 
I will use the data from your milk sample along with other samples to write aboutthe influence 
of storage container materials, including glass and different plastics, IgA.  I will send a copy of 
my final thesis if you want to see it. 
 
Your personal information will be kept confidential. 
 




I guarantee that the following conditions will be met: 
 
1.) Your real name will not be used at any point of information collection after the donation of 
your milk.  The written records, data, and final thesis will only use letters to repres nt you. 
 
2.) Your participation in this research is voluntary; you have the right to withdraw at any point 
of the study, for any reason, and without any prejudice, and the information collected from 
you will be omitted from the study. 
 
3.) You may ask for a copy of the published thesis for you to keep. 
 
 




Yes_____________    No ___________ 
 
 
By signing this, you are agreeing to the terms written above: 
 
 


































How many weeks or months have passed since your delivery? 
 
 
__________________________________________    
          
 
 
